High predictive value of epidermal growth factor receptor phosphorylation but not of EGFRvIII mutation in resected stage I non-small cell lung cancer (NSCLC)
Data up to Jan 2025
Total Citations Per Year
Abstract
References (43)
Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer
2003 • 2,874 citations
Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients With Non–Small Cell Lung Cancer
2003 • 2,522 citations
Global cancer statistics in the year 2000
2001 • 2,471 citations
EGFR and cancer prognosis
2001 • 2,068 citations
The new World Health Organization classification of lung tumours
2001 • 1,131 citations
Crystal structure of the tyrosine kinase domain of the human insulin receptor
1994 • 1,071 citations
c-Src-mediated Phosphorylation of the Epidermal Growth Factor Receptor on Tyr845 and Tyr1101 Is Associated with Modulation of Receptor Function
1999 • 633 citations
Frequent expression of a mutant epidermal growth factor receptor in multiple human tumors.
1995 • 633 citations
The Enhanced Tumorigenic Activity of a Mutant Epidermal Growth Factor Receptor Common in Human Cancers Is Mediated by Threshold Levels of Constitutive Tyrosine Phosphorylation and Unattenuated Signaling
1997 • 591 citations
In vivo enhancement of tumor radioresponse by C225 antiepidermal growth factor receptor antibody.
2000 • 498 citations
Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lung carcinomas and malignant gliomas.
1995 • 465 citations
Epidermal growth factor receptor (EGFR) and EGFR mutations, function and possible role in clinical trials
1997 • 456 citations
Epidermal growth factor receptor and HER2-neu mRNA expression in non-small cell lung cancer Is correlated with survival.
2001 • 455 citations
Development of ABX-EGF, a fully human anti-EGF receptor monoclonal antibody, for cancer therapy
2001 • 452 citations
Overexpression of the epidermal growth factor receptor and its ligand transforming growth factor alpha is frequent in resectable non-small cell lung cancer but does not predict tumor progression.
1997 • 404 citations
Lung cancer : principles and practice
1996 • 345 citations
Immunocytochemical markers in stage I lung cancer: relevance to prognosis.
1997 • 313 citations
Constitutive Activation of Phosphatidylinositol 3-Kinase by a Naturally Occurring Mutant Epidermal Growth Factor Receptor
1998 • 304 citations
A prognostic model of recurrence and death in stage I non-small cell lung cancer utilizing presentation, histopathology, and oncoprotein expression.
1995 • 300 citations
Epidermal growth factor receptor overexpression correlates with a poor prognosis in completely resected non-small-cell lung cancer
2003 • 282 citations
Functional characterization of an EGF receptor with a truncated extracellular domain expressed in glioblastomas with EGFR gene amplification.
1994 • 255 citations
Expression of mutated epidermal growth factor receptor by non-small cell lung carcinomas.
1993 • 246 citations
The type III epidermal growth factor receptor mutation
2001 • 241 citations
Expression of Activated Epidermal Growth Factor Receptors, Ras-Guanosine Triphosphate, and Mitogen-activated Protein Kinase in Human Glioblastoma Multiforme Specimens
1999 • 230 citations
Growth suppression of intracranial xenografted glioblastomas overexpressing mutant epidermal growth factor receptors by systemic administration of monoclonal antibody (mAb) 806, a novel monoclonal antibody directed to the receptor.
2001 • 204 citations
Transformational and altered signal transduction by a naturally occurring mutant EGF receptor.
1996 • 195 citations
Receptor dimerization is not a factor in the signalling activity of a transforming variant epidermal growth factor receptor (EGFRvIII)
1997 • 186 citations
Enhanced Tumorigenic Behavior of Glioblastoma Cells Expressing a Truncated Epidermal Growth Factor Receptor Is Mediated through the Ras-Shc-Grb2 Pathway
1996 • 175 citations
A comparison of epidermal growth factor receptor levels and other prognostic parameters in non-small cell lung cancer
1996 • 152 citations
Regulation of postendocytic trafficking of the epidermal growth factor receptor through endosomal retention.
1994 • 144 citations
Novel Targets for Lung Cancer Therapy: Part I
2002 • 141 citations
Glycosylation-induced Conformational Modification Positively Regulates Receptor-Receptor Association
2001 • 137 citations
Synchronous Overexpression of Epidermal Growth Factor Receptor and HER2- neu Protein Is a Predictor of Poor Outcome in Patients with Stage I Non-Small Cell Lung Cancer
2004 • 136 citations
Expression of constitutively activated EGFRvlll in non‐small cell lung cancer
2003 • 129 citations
Epidermal growth factor receptor (EGFr) expression in non-small cell lung carcinomas correlates with metastatic involvement of hilar and mediastinal lymph nodes in the squamous subtype
1995 • 123 citations
Increased epidermal growth factor receptor expression in metaplastic bronchial epithelium.
1996 • 103 citations
Phosphorylation, But Not Overexpression, of Epidermal Growth Factor Receptor Is Associated With Poor Prognosis of Non-Small Cell Lung Cancer Patients
2003 • 81 citations
Mutant Epidermal Growth Factor Receptors as Targets for Cancer Therapy
2002 • 70 citations
Enzyme-linked immunosorbent assay of epidermal growth factor receptor in lung cancer: comparisons with immunohistochemistry, clinicopathological features and prognosis
1998 • 45 citations
Immunohistochemical typing of non-small cell lung cancer on cryostat sections: correlation with clinical parameters and prognosis
2003 • 31 citations
Intracellular expression of the truncated extracellular domain of c-erbB-3/HER3
2001 • 22 citations
Ongoing and future trials of biologic therapies in lung cancer
2003 • 20 citations
Characterisation and predictive value of epidermal growth factor receptor status using quantitative real-time PCR combined with immunohistochemistry on non-small cell lung cancer specimens
2003 • 9 citations